AvalehtNHIQ • OTCMKTS
add
NantHealth Inc
Viimane sulgemishind
0,00010 $
Tänane vahemik
0,00010 $ - 0,00010 $
Turuväärtus
2,75 tuh USD
Keskmine maht
187,00
P/E suhe
-
Dividendimäär
-
Põhibörs
OTCMKTS
Börsiuudised
NDAQ
2,42%
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(USD) | sept 2023info | Y/Y muutus |
---|---|---|
Käive | 12,47 mln | — |
Põhitegevusega seonduv kulu | 12,17 mln | — |
Puhastulu | −14,99 mln | — |
Puhaskasumimarginaal | −120,20 | — |
Puhaskasum aktsia kohta | — | — |
EBITDA | −175,00 tuh | — |
Tõhus maksumäär | −0,36% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(USD) | sept 2023info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 5,82 mln | — |
Kogu vara | 146,48 mln | — |
Kõik kohustused | 396,66 mln | — |
Kogu omakapital | −250,18 mln | — |
Emiteeritud aktsiate arv | 27,47 mln | — |
Hinna ja väärtuse suhe P/B | −0,00 | — |
Varade tasuvus | −8,24% | — |
Kapitali tasuvus | −41,68% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(USD) | sept 2023info | Y/Y muutus |
---|---|---|
Puhastulu | −14,99 mln | — |
Põhitegevuse rahakäive | −7,65 mln | — |
Investeeringute raha | 11,00 tuh | — |
Finantseerimise raha | 7,50 mln | — |
Raha ja raha ekvivalentide muutus | −298,00 tuh | — |
Tasuta rahavoog | −3,94 mln | — |
Teave
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Tegevjuht
Asutatud
7. juuli 2010
Veebisait
Töötajate arv
373